Study wrapper · #25
Endothelium-Dependent Nitric Oxide-Mediated Vasorelaxant Effects of BPC 157 in Human Internal Mammary Artery.
Editor's note
This in-vitro study provides the first direct evidence that BPC-157 can induce vasorelaxation in human arterial tissue — specifically residual internal mammary artery segments collected from 12 patients undergoing coronary bypass surgery. Researchers found a concentration-dependent reduction in phenylephrine-induced contraction, with significantly greater relaxation in endothelium-intact rings compared to denuded ones. NOS inhibition with L-NAME substantially attenuated these effects, implicating the endothelial nitric oxide pathway as the primary mediating mechanism. A residual relaxation effect persisted under NOS blockade, suggesting additional, as-yet-uncharacterised pathways.
The finding matters because BPC-157's vasodilatory effects had previously been demonstrated only in animal models; this is the first mechanistic signal in human tissue. That said, ex-vivo ring preparations are not equivalent to intact vascular physiology — there is no circulating milieu, no autonomic tone, and no systemic pharmacokinetics. The sample size of 12 donors is small, and the study cannot establish dose relevance for any in-vivo context.
This work adds a meaningful mechanistic datapoint to...
Plain-language abstract
Researchers set out to test whether BPC-157, a synthetic 15-amino-acid peptide derived from a protein found in human gastric juice, could relax blood vessel walls in human arterial tissue, and to identify the biological pathway responsible.
The team used leftover segments of the internal mammary artery — the blood vessel commonly harvested during coronary bypass surgery — from 12 patients. These artery segments were prepared as small rings in a laboratory setting, either with the vessel's inner lining (endothelium) intact or deliberately removed. Each ring was first made to contract using a drug called phenylephrine, then exposed to increasing doses of BPC-157 to observe whether the contraction eased.
Results showed that BPC-157 produced a dose-dependent relaxation of the contracted artery rings. This relaxation was significantly greater in rings with an intact inner lining. When researchers pre-treated rings with a drug (L-NAME) that blocks nitric oxide production, the relaxing effect of BPC-157 was substantially reduced, and the difference between intact and stripped rings largely disappeared. This points to the endothelium-dependent nitric oxide pathway as the main mechanism. Some residual relaxation remained even after nitric oxide was blocked, suggesting other mechanisms may also be involved.
No adverse events were reported, as this was a laboratory tissue study. The authors note that further molecular and whole-organism studies are required before these findings...